GPCR icon

Structure Therapeutics
GPCR

Overview Fund Activity

166 hedge funds and large institutions have $2.33B invested in Structure Therapeutics in 2024 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 63 increasing their positions, 33 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
166
Holders Change
+47
Holders Change %
+39.5%
% of All Funds
2.41%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
61
Increased
63
Reduced
33
Closed
13
Calls
$53.3M
Puts
$25.1M
Net Calls
+$28.2M
Net Calls Change
-$13.5M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$226M
2
Wellington Management Group
Wellington Management Group
Massachusetts
$296M
3
BI
BVF Inc
California
$97.7M
4
Capital Research Global Investors
Capital Research Global Investors
California
$123M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
$132M

Top Sellers

1
TCM
TCG Crossover Management
California
$27.3M
2
HH
HSG Holding
Hong Kong
$10.3M
3
FLSM
Frazier Life Sciences Management
California
$0
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
$27.8M
5
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
$27.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
BCM
176
Bayesian Capital Management
New York
– -$262K -6,108 Closed
YIH
177
Y-Intercept (HK)
Hong Kong
– -$209K -4,867 Closed
SGH
178
Sivik Global Healthcare
Connecticut
– -$191K -4,464 Closed
JFG
179
Jefferies Financial Group
New York
– -$85.7K -2,000 Closed
4 5 6 7
8